VANCOMYCIN

被引：58

作者：

CUNHA, BA ^{[1
]}

机构：

[1] SUNY STONY BROOK,SCH MED,STONY BROOK,NY 11794

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1995年 / 79卷 / 04期

关键词：

D O I：

10.1016/S0025-7125(16)30041-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Vancomycin is a nontoxic glycopeptide antibiotic most often used to treat serious gram-positive infections, Clostridium difficile diarrhea/colitis, and endocarditis and hemodialysis shunt prophylaxis. Vancomycin should not be added to drug regimens for gram-positive coverage, and the empiric use of vancomycin should be discouraged to avoid the emergence of vancomycin-resistant enterococci.

引用

页码：817 / 831

页数：15

共 58 条

[1] REVIEW OF VANCOMYCIN - AFTER 15 YEARS OF USE [J].

ALEXANDE.MR .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (09) :520-525

[2] VANCOMYCIN OTOTOXICITY AND NEPHROTOXICITY - A REVIEW [J].

BAILIE, GR ;

NEAL, D .

MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (05) :376-386

[3]

BARTLETT JG, 1979, REV INFECT DIS, V1, P530

[4]

BARTLETT JG, 1992, INFECT DIS PRACT, V16, P1

[5] VANCOMYCIN-AMINOGLYCOSIDE COMBINATIONS IN THERAPY OF ENDOCARDITIS CAUSED BY ENTEROCOCCUS SPECIES AND STREPTOCOCCUS-BOVIS [J].

BESNIER, JM ;

LEPORT, C ;

BURE, A ;

VILDE, JL .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (02) :130-133

[6]

CANTU TG, 1994, CLIN INFECT DIS, V18, P533

[7]

CHOW AW, 1993, EUR J HAEMATOL S, V54, P18

[8] VANCOMYCIN REVISITED [J].

COOK, FV ;

FARRAR, WE .

ANNALS OF INTERNAL MEDICINE, 1978, 88 (06) :813-818

[9]

CUNHA BA, 1981, REV INFECT DIS, V3, pS269

[10]

CUNHA BA, 1983, CLIN PHARMACY, V2, P417

← 1 2 3 4 5 6 →